EMPagliflozin After Aortic Valve Replacement

NCT06171802 · clinicaltrials.gov ↗

PHASE4

Phase

ACTIVE_NOT_RECRUITING

Status

205

Enrollment

OTHER

Sponsor class

Conditions

Aortic Valve Stenosis

Interventions

DRUG: Empagliflozin
DRUG: Placebo

Sponsor

Rigshospitalet, Denmark